Liang Su
About
Liang Su has authored 20 papers that have received a total of 851 indexed citations.
This includes 10 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Oncology. The topics of these papers are COVID-19 Clinical Research Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Liang Su is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers) and collaborates with scholars based in China and United States. Liang Su's co-authors include Dong Liang, Huan Xie, Jing Ma, Cheng‐Bao Zhu and Zhongfa Zhang and has published in prestigious journals such as ACS Nano, PLoS ONE and Frontiers in Immunology.
In The Last Decade
Fields of papers published by Liang Su
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries citing papers authored by Liang Su
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Denitsa Eckweiler Breakdown of academic impact, for papers by Thomas G. Gross Breakdown of academic impact, for papers by Subhadeep Sarkar Breakdown of academic impact, for papers by Raz Ben-Yair Breakdown of academic impact, for papers by Linda S. Steinberg Breakdown of academic impact, for papers by A. O’Meara Breakdown of academic impact, for papers by Ronald Wall Breakdown of academic impact, for papers by Peter Möller